BioMed X Institute and Boehringer Ingelheim Successfully Complete Schizophrenia Research Project
German independent research institute BioMed X announces the successful completion of its second neuroscience project in partnership with Boehringer Ingelheim in the field of psychiatric disorders. The data resulting from this project have been acquired by Boehringer Ingelheim, where this research will be ...
Baden Wüberg Hugh Marston Ercan Herbst Ebru Ercan Herbst Christian Tidona Discovery Research At Boehringer Ingelheim
Source: pharmiweb.com